Skip to search formSkip to main contentSkip to account menu

glucagon (19-29)

Known as: des(1-18) glucagon, glucagon(19-29), miniglucagon 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

GlucagonPeptide Fragments

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Postabsorptive hyperglucagonemia in patients with type 2 diabetes mellitus analyzed with a novel enzyme‐linked immunosorbent assay
The aims of the present study were to investigate the performance of a novel sandwich enzyme‐linked immunosorbent assay (ELISA… 
2014
2014
Role of glutamine-169 in the substrate recognition of human aminopeptidase B.
2010
2010
Prolonged GIP receptor activation improves glucose homeostasis and cognitive function in high-fat fed mice
Review
2006
Review
2006
The Glucagon–Miniglucagon Interplay
Abstract:  Miniglucagon (glucagon 19–29) is the ultimate processing product of proglucagon, present in the glucagon‐secreting… 
2003
2003
Endosomal proteolysis of glucagon at neutral pH generates the bioactive degradation product miniglucagon-(19-29).
We have investigated the proteolytic mechanisms of glucagon degradation within hepatic endosomes at neutral pH before lumen… 
2002
2002
Miniglucagon (glucagon 19-29): a novel regulator of the pancreatic islet physiology.
Miniglucagon, the COOH-terminal (19-29) fragment processed from glucagon, is a potent and efficient inhibitor of insulin… 
1999
1999
Miniglucagon (Glucagon 19–29), a Potent and Efficient Inhibitor of Secretagogue-induced Insulin Release through a Ca2+Pathway*
Using the MIN6 B-cell line, we investigated the hypothesis that miniglucagon, the C-terminal (19-29) fragment processed from… 
1996
1996
Synergistic actions of glucagon and miniglucagon on Ca2+ mobilization in cardiac cells.
It has been recently shown that the physiological processing of glucagon into its C-terminal (19-29) fragment, miniglucagon, by… 
Review
1994
Review
1994
Miniglucagon production from glucagon: an extracellular processing of a hormone used as a prohormone.
1991
1991
Miniglucagon [glucagon-(19-29)] is a component of the positive inotropic effect of glucagon.
Glucagon is well known for its cardiotonic effect, but its mechanism of action remains undetermined. In the present study, we… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)